Conclusion and Recommendations
1. The Panel reject India's claims that the laws, rules and regulations of the United States that authorize the imposition of the EBR and the instruments comprising the Amended CBD are inconsistent as such with the provisions of Articles 1, 7.1（iii）, 7.2, 7.4, 9.1, 9.2, 9.3 （including 9.3.1）, 18.1 and 18.4 of the Anti-Dumping Agreement; Articles 10, 17.1（c）, 17.2, 17.4, 19.2, 19.3, 19.4 and 32.1 of the SCM Agreement; Articles Ⅵ:2 and Ⅵ:3 of the GATT 1994; and the Ad Note thereto.